253 related articles for article (PubMed ID: 12875753)
1. The incidence and risk factors of cholesterol embolization syndrome, a complication of cardiac catheterization: a prospective study.
Fukumoto Y; Tsutsui H; Tsuchihashi M; Masumoto A; Takeshita A;
J Am Coll Cardiol; 2003 Jul; 42(2):211-6. PubMed ID: 12875753
[TBL] [Abstract][Full Text] [Related]
2. Cholesterol emboli after invasive cardiac procedures.
Bashore TM; Gehrig T
J Am Coll Cardiol; 2003 Jul; 42(2):217-8. PubMed ID: 12875754
[No Abstract] [Full Text] [Related]
3. Cholesterol embolization syndrome.
Saric M; Kronzon I
Curr Opin Cardiol; 2011 Nov; 26(6):472-9. PubMed ID: 21993354
[TBL] [Abstract][Full Text] [Related]
4. [Clinical evaluation of cholesterol embolization syndrome after cardiac catheterization].
Izumi C; Kondo H; Tamura T; Inoko M; Kitaguchi S; Himura Y; Iga K; Gen H; Konishi T
J Cardiol; 1998 Apr; 31(4):201-6. PubMed ID: 9594368
[TBL] [Abstract][Full Text] [Related]
5. Cholesterol crystal embolization (CCE) after cardiac catheterization: a case report and a review of 36 cases in the Japanese literature.
Funabiki K; Masuoka H; Shimizu H; Emi Y; Mori T; Ito M; Nakano T
Jpn Heart J; 2003 Sep; 44(5):767-74. PubMed ID: 14587658
[TBL] [Abstract][Full Text] [Related]
6. Livedo reticularis: an underutilized diagnostic clue in cholesterol embolization syndrome.
Chaudhary K; Wall BM; Rasberry RD
Am J Med Sci; 2001 May; 321(5):348-51. PubMed ID: 11370799
[TBL] [Abstract][Full Text] [Related]
7. [Livedo reticularis, acral necroses and renal failure. Cholesterol crystal embolisms].
Osterwalder P; Goehde SC; Stürmer J; Vetter W
Praxis (Bern 1994); 1998 Apr; 87(14):483-90. PubMed ID: 9587225
[TBL] [Abstract][Full Text] [Related]
8. Cholesterol embolization syndrome: An under-recognized entity in cardiovascular interventions.
Agrawal A; Ziccardi MR; Witzke C; Palacios I; Rangaswami J
J Interv Cardiol; 2018 Jun; 31(3):407-415. PubMed ID: 29243285
[TBL] [Abstract][Full Text] [Related]
9. [Digital ischemia, renal failure and livedo reticularis after fibrinolysis. Cholesterol embolism].
Ena J; Gutiérrez F; Gómez A; Vilar A
Rev Clin Esp; 1996 Mar; 196(3):187-8. PubMed ID: 8650391
[No Abstract] [Full Text] [Related]
10. [Cholesterol crystal embolism and renal insufficiency: case report and literature review].
Puksić S; Haris V; Ljubanović D; Durasević Z; Galesić K
Lijec Vjesn; 2009; 131(9-10):254-9. PubMed ID: 20030288
[TBL] [Abstract][Full Text] [Related]
11. Association between absolute blood eosinophil count and CKD stages among cardiac patients.
Ishii R; Fujita S; Kizawa S; Sakane K; Morita H; Ozeki M; Sohmiya K; Hoshiga M; Ishizaka N
Heart Vessels; 2016 Feb; 31(2):198-205. PubMed ID: 25325991
[TBL] [Abstract][Full Text] [Related]
12. Cholesterol embolization syndrome: cutaneous histopathological features and the variable onset of symptoms in patients with different risk factors.
Pennington M; Yeager J; Skelton H; Smith KJ
Br J Dermatol; 2002 Mar; 146(3):511-7. PubMed ID: 11952556
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes of renal cholesterol crystal embolization.
Kazancioğlu R; Erkoç R; Bozfakioğlu S; Türk S; Gören T; Kayacan SM; Kiliçaslan I; Baykal C; Büyükbabani N; Aysuna N; Ark E
J Nephrol; 1999; 12(4):266-9. PubMed ID: 10493571
[TBL] [Abstract][Full Text] [Related]
14. Combined assessment of carotid vulnerable plaque, renal insufficiency, eosinophilia, and hs-CRP for predicting risky aortic plaque of cholesterol crystal embolism.
Machino-Ohtsuka T; Seo Y; Ishizu T; Sekiguchi Y; Sato A; Tada H; Watanabe S; Aonuma K
Circ J; 2010 Jan; 74(1):51-8. PubMed ID: 19966505
[TBL] [Abstract][Full Text] [Related]
15. Cholesterol embolization syndrome: A report of two cases.
Dizman N; Aydın Bahat K; Özkanlı Ş; Özkök A
Turk Kardiyol Dern Ars; 2016 Apr; 44(3):251-5. PubMed ID: 27138317
[TBL] [Abstract][Full Text] [Related]
16. Use of corticosteroids in the treatment of cholesterol crystal embolism after cardiac catheterization: a report of four Japanese cases.
Masuda J; Tanigawa T; Nakamori S; Sawai T; Murata T; Ishikawa E; Yamada N; Nakamura M; Ito M
Intern Med; 2013; 52(9):993-8. PubMed ID: 23648720
[TBL] [Abstract][Full Text] [Related]
17. [Atheroembolic renal disease: analysis of clinical and therapeutic factors that influence its progression].
Gutiérrez Solís E; Morales E; Rodríguez Jornet A; Andreu FJ; Rivera F; Vozmediano C; Gutiérrez E; Igarzábal A; Enguita AB; Praga M
Nefrologia; 2010; 30(3):317-23. PubMed ID: 20414329
[TBL] [Abstract][Full Text] [Related]
18. LDL apheresis for cholesterol embolism following coronary artery bypass graft surgery--a case report.
Sanai T; Matsui R; Hirano T
Angiology; 2006; 57(3):379-82. PubMed ID: 16703200
[TBL] [Abstract][Full Text] [Related]
19. Cholesterol crystal embolism: A recognizable cause of renal disease.
Scolari F; Tardanico R; Zani R; Pola A; Viola BF; Movilli E; Maiorca R
Am J Kidney Dis; 2000 Dec; 36(6):1089-109. PubMed ID: 11096032
[TBL] [Abstract][Full Text] [Related]
20. Acute renal failure due to cholesterol crystal embolism treated with LDL apheresis followed by corticosteroid and candesartan.
Tamura K; Umemura M; Yano H; Sakai M; Sakurai Y; Tsurumi Y; Koide Y; Usui T; Yabana M; Toya Y; Tokita Y; Umemura S
Clin Exp Nephrol; 2003 Mar; 7(1):67-71. PubMed ID: 14586747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
